Bio-View Ltd (BIOV.TA)
ILA 30.4
(-1.62%)
ILA 30.4
(-1.62%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 34.76 Million ILS | 19.29% |
| 2022 | 29.14 Million ILS | -4.48% |
| 2021 | 30.51 Million ILS | 17.54% |
| 2020 | 25.96 Million ILS | -27.47% |
| 2019 | 35.79 Million ILS | 41.57% |
| 2018 | 25.28 Million ILS | -8.93% |
| 2017 | 27.76 Million ILS | -16.61% |
| 2016 | 33.28 Million ILS | -3.61% |
| 2015 | 34.53 Million ILS | 14.19% |
| 2014 | 30.24 Million ILS | 31.34% |
| 2013 | 23.02 Million ILS | -11.6% |
| 2012 | 26.04 Million ILS | -0.47% |
| 2011 | 26.16 Million ILS | 3.36% |
| 2010 | 25.31 Million ILS | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 8.52 Million ILS | 0.0% |
| 2024 Q1 | 8.52 Million ILS | -1.5% |
| 2023 Q4 | 8.65 Million ILS | 0.0% |
| 2023 FY | 34.76 Million ILS | 19.29% |
| 2023 Q3 | 8.65 Million ILS | -0.94% |
| 2023 Q2 | 8.73 Million ILS | 0.0% |
| 2023 Q1 | 8.73 Million ILS | 5.76% |
| 2022 Q2 | 5.51 Million ILS | -21.01% |
| 2022 FY | 29.14 Million ILS | -4.48% |
| 2022 Q4 | 8.25 Million ILS | -1.62% |
| 2022 Q3 | 8.39 Million ILS | 52.21% |
| 2022 Q1 | 6.98 Million ILS | -14.9% |
| 2021 Q2 | 5.82 Million ILS | -21.64% |
| 2021 Q1 | 7.43 Million ILS | 2.67% |
| 2021 FY | 30.51 Million ILS | 17.54% |
| 2021 Q3 | 9.04 Million ILS | 55.32% |
| 2021 Q4 | 8.2 Million ILS | -9.35% |
| 2020 FY | 25.96 Million ILS | -27.47% |
| 2020 Q4 | 7.24 Million ILS | -4.81% |
| 2020 Q2 | 5.65 Million ILS | 3.7% |
| 2020 Q3 | 7.6 Million ILS | 34.51% |
| 2020 Q1 | 5.45 Million ILS | -47.61% |
| 2019 Q4 | 10.41 Million ILS | 4.38% |
| 2019 FY | 35.79 Million ILS | 41.57% |
| 2019 Q3 | 9.97 Million ILS | 11.14% |
| 2019 Q1 | 6.43 Million ILS | -22.19% |
| 2019 Q2 | 8.97 Million ILS | 39.46% |
| 2018 Q3 | 5.07 Million ILS | -31.86% |
| 2018 FY | 25.28 Million ILS | -8.93% |
| 2018 Q1 | 4.49 Million ILS | -45.58% |
| 2018 Q2 | 7.44 Million ILS | 65.45% |
| 2018 Q4 | 8.26 Million ILS | 63.06% |
| 2017 Q2 | 5.61 Million ILS | 0.0% |
| 2017 FY | 27.76 Million ILS | -16.61% |
| 2017 Q4 | 8.26 Million ILS | 0.0% |
| 2017 Q3 | 8.26 Million ILS | 47.2% |
| 2017 Q1 | 5.61 Million ILS | -42.93% |
| 2016 Q1 | 7.05 Million ILS | -33.89% |
| 2016 FY | 33.28 Million ILS | -3.61% |
| 2016 Q4 | 9.83 Million ILS | 29.31% |
| 2016 Q3 | 7.6 Million ILS | -13.41% |
| 2016 Q2 | 8.78 Million ILS | 24.5% |
| 2015 Q2 | 8.82 Million ILS | -2.9% |
| 2015 Q1 | 9.08 Million ILS | 10.23% |
| 2015 Q3 | 5.95 Million ILS | -32.5% |
| 2015 FY | 34.53 Million ILS | 14.19% |
| 2015 Q4 | 10.67 Million ILS | 79.29% |
| 2014 Q2 | 7.66 Million ILS | 7.97% |
| 2014 FY | 30.24 Million ILS | 31.34% |
| 2014 Q4 | 8.24 Million ILS | 14.0% |
| 2014 Q1 | 7.1 Million ILS | 9.58% |
| 2014 Q3 | 7.22 Million ILS | -5.74% |
| 2013 Q1 | 5.86 Million ILS | 0.0% |
| 2013 Q2 | 5.03 Million ILS | -14.23% |
| 2013 Q3 | 5.64 Million ILS | 12.12% |
| 2013 Q4 | 6.48 Million ILS | 14.87% |
| 2013 FY | 23.02 Million ILS | -11.6% |
| 2012 FY | 26.04 Million ILS | -0.47% |
| 2011 FY | 26.16 Million ILS | 3.36% |
| 2010 FY | 25.31 Million ILS | 0.0% |
| Name | Revenue | Revenue Difference |
|---|